Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
2020 · Nature · 849 citations
https://doi.org/10.1038/s41586-020-2577-1
R
Raveen Rathnasinghe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
4.4K
Citations
23
h-index
40
i10-index
Raveen Rathnasinghe is an academic researcher from Seqirus (United States). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Influenza Virus Research Studies & Respiratory viral infections research. The author has an h-index of 23, co-authored 63 publications.
ORCID: 0000-0002-1260-2493Papers by this author
worksMicrobiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection
2020 · Nature Communications · 122 citations
https://doi.org/10.1038/s41467-020-16429-9
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
2021 · Nature Communications · 117 citations
https://doi.org/10.1038/s41467-021-26499-y
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
2023 · Cell Host & Microbe · 73 citations
https://doi.org/10.1016/j.chom.2023.08.003
Limited extent and consequences of pancreatic SARS-CoV-2 infection
2022 · Cell Reports · 56 citations
https://doi.org/10.1016/j.celrep.2022.110508
Scalable, effective, and rapid decontamination of SARS-CoV-2 contaminated N95 respirators using germicidal ultraviolet C (UVC) irradiation device
2021 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-021-99431-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat